Dr. Wasim E. Deeb, MD

Dr. Deeb practices at First Choice Endocrinology in Jacksonville, Florida.

Dr. Deeb's NPI, 1881700698, was assigned on August 22, 2006. Dr. Deeb graduated from Damascus University Faculty of Medicine in 1994. Dr. Deeb holds Florida license ME102044.

Dr. Deeb's primary practice is First Choice Endocrinology, at 8837 Goodbys Executive Dr, Jacksonville, FL 32217 in Duval County. The practice phone is (904) 990-0555.

Dr. Deeb's primary practice is First Choice Endocrinology in Jacksonville, Florida. Dr. Deeb is also affiliated with Baptist Medical Center Jacksonville. The medical group on file is First Choice Endocrinology. Dmand AI also links Dr. Deeb to 4 more hospitals, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Deeb practices, 7 sites in all. Vendor and product names are available with a free account.

Endocrinology, diabetes and metabolism is Dr. Deeb's primary specialty in the NPI Registry, under taxonomy code 207RE0101X. Dr. Deeb is board certified in endocrinology, diabetes and metabolism by the American Board of Internal Medicine. Dmand AI has Dr. Deeb's licenses on file in 3 states: Florida, Ohio and Pennsylvania.

Dmand AI lists chronic diabetes, diabetic emergency, enlarged thyroid, high cholesterol, obesity, osteoporosis, overactive thyroid and parathyroid gland disorder among the conditions Dr. Deeb treats.

CMS data shows 17,203 Medicare services from Dr. Deeb across 13 procedure codes in 2024, for 853 Medicare patients. Medicare paid $473,097 for them. Every service was in an office.

CMS counts 853 Medicare patients who saw Dr. Deeb in 2024. The largest group is 65 to 74, with 415 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.35, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Deeb's median patient age at 57, with 66% women.

In 2024, Dr. Deeb wrote 12,546 Medicare Part D claims for 1,154 patients. 57% of them were for generic drugs. CMS names the drug for 12,069 of them, across 98 drugs with 11 or more claims each, at $4,036,100 in total drug cost. In 2023, CMS named 11,627 claims across 96 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Deeb for performance year 2024, reported individually. Dr. Deeb accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Deeb as offering telehealth.

Dmand AI links 4 papers to Dr. Deeb, published from 2024 to 2025. 2024 was the busiest year, with 2. The most frequent topics are Diabetes Mellitus, Type 2, Blood Glucose and Glycated Hemoglobin. Dr. Deeb's most frequent co-authors are Jason Andrew Berner, MD, David Rickenbeck Sutton, MD and Yazan Hani Alkhouri, MD.

CMS Open Payments shows 3,148 general payments to Dr. Deeb from 84 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 82% of the total. AstraZeneca Pharmaceuticals LP paid the most, $143,892.

Dr. Deeb graduated from Damascus University Faculty of Medicine in 1994.

Dr. Deeb is in network with 14 carriers, including Aetna, United Healthcare and Elevance. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.